Maximum Strength Antacid Cherry

Description

EQUALINE® maximum strength antacid liquid is formulated to provide effective relief from heartburn and indigestion. Each 10 mL dose contains 800 mg of aluminum hydroxide and 800 mg of magnesium hydroxide, both serving as antacids, along with 80 mg of simethicone, which acts as an antigas agent. The product is presented in a cherry flavor and is available in a 12 FL OZ (355 mL) bottle.

Uses and Indications

This drug is indicated for the relief of symptoms associated with acid indigestion, heartburn, sour stomach, and upset stomach, including gas. It effectively alleviates heartburn, acid indigestion, and gas, providing symptomatic relief for patients experiencing these gastrointestinal disturbances.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to instruct patients to shake the product well before use.

For adults and children aged 12 years and older, the recommended dosage is 10 to 20 mL administered two times a day, or as directed by a physician.

For children under 12 years of age, it is essential to consult a healthcare provider for appropriate dosing recommendations.

All dosages are to be measured in milliliters (mL).

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional if symptoms persist for more than two weeks.

Warnings and Precautions

The maximum recommended dosage of this product is 60 mL within a 24-hour period. It is imperative that this dosage is not exceeded, nor should the maximum dosage be utilized for more than two weeks, unless under the guidance and supervision of a healthcare professional.

Patients should discontinue use and consult a physician if symptoms persist beyond two weeks.

Prior to use, individuals should seek medical advice if they have a history of kidney disease or are on a magnesium-restricted diet. Additionally, it is advisable for patients to consult with a healthcare provider or pharmacist if they are currently taking any prescription medications, as antacids may interact with certain drugs.

No specific laboratory tests are recommended for monitoring in conjunction with the use of this product.

Side Effects

Patients should be aware of the potential adverse reactions associated with this product. It is crucial to adhere to the recommended dosage guidelines, which state that no more than 60 mL should be taken within a 24-hour period, and the maximum dosage should not be used for more than two weeks unless under the advice and supervision of a healthcare professional.

In the event that symptoms persist for more than two weeks, patients are advised to stop use and consult a doctor. Additionally, individuals with kidney disease or those on a magnesium-restricted diet should seek medical advice before using this product.

Furthermore, patients currently taking prescription medications should consult with a doctor or pharmacist prior to use, as antacids may interact with certain prescription drugs. These precautions are essential to ensure the safe and effective use of the product.

Drug Interactions

Antacids may interact with various prescription medications, potentially affecting their absorption and efficacy. It is advisable to separate the administration of antacids and other medications by at least two hours to minimize the risk of interaction. Monitoring for therapeutic effectiveness of the affected drugs is recommended when antacids are used concurrently.

Packaging & NDC

Below are the non-prescription pack sizes of Maximum Strength Antacid Cherry (aluminum hydroxide, magnesium hydroxide, simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and children aged 12 years and older, the recommended dosage is 10 to 20 mL taken twice daily, or as directed by a healthcare provider.

Geriatric Use

Elderly patients should exercise caution when using this medication, particularly those aged 65 and older. It is advisable for geriatric patients to consult a healthcare provider before use if they have a history of kidney disease, as this condition may affect the safety and efficacy of the treatment.

Additionally, elderly patients are encouraged to seek guidance from a doctor or pharmacist if they are currently taking any prescription medications. This is important because antacids may interact with certain prescription drugs, potentially leading to adverse effects or diminished therapeutic outcomes.

For adults and children aged 12 years and older, the recommended dosage is 10 to 20 mL taken twice daily, or as directed by a healthcare professional. For children under 12 years of age, it is essential to consult a doctor prior to administration to ensure appropriate dosing and safety.

Monitoring and dose adjustments may be necessary based on individual patient factors, particularly in the geriatric population, to mitigate risks and enhance treatment effectiveness.

Pregnancy

The available data regarding the use of this medication during pregnancy do not indicate specific safety concerns. There are no documented dosage modifications required for pregnant individuals, nor are there any special precautions outlined for use during pregnancy. Healthcare professionals should consider the overall clinical context when prescribing this medication to pregnant patients, as individual circumstances may vary. As with any medication, the potential benefits should be weighed against any risks to fetal outcomes, although no specific risks have been identified in the available information.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or toxicology experts for guidance on specific management protocols and interventions tailored to the situation.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Patients should be informed to discontinue use and consult a doctor if their symptoms persist for more than two weeks, as this may indicate a need for further evaluation.

It is important for patients to seek medical advice before using this medication if they have a history of kidney disease or are on a magnesium-restricted diet. Additionally, patients should be encouraged to discuss their current medications with their healthcare provider or pharmacist, particularly if they are taking prescription drugs, as antacids may interact with certain medications. This precaution helps ensure safe and effective use of the product.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored at a controlled room temperature of 20ºC to 25ºC (68ºF to 77ºF). Freezing is strictly prohibited, as it may compromise the integrity of the product. Proper handling and storage conditions are essential to maintain the product's efficacy and safety.

Additional Clinical Information

The medication is administered orally. For adults and children aged 12 years and older, the recommended dosage is 10 to 20 mL taken twice daily, or as directed by a healthcare professional. For children under 12 years of age, it is advised to consult a doctor for appropriate dosing guidance.

There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Maximum Strength Antacid Cherry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)